<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37808221</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2211-7539</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Medical mycology case reports</Title><ISOAbbreviation>Med Mycol Case Rep</ISOAbbreviation></Journal><ArticleTitle>Cutaneous mucormycosis in the immunocompromised host: An important cause of persistent post traumatic skin lesions.</ArticleTitle><Pagination><StartPage>100607</StartPage><MedlinePgn>100607</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100607</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mmcr.2023.100607</ELocationID><Abstract><AbstractText>We describe a case of a 31-year-old man with a history of ocular non-Hodgkin's lymphoma who presented with a large 12-cm non-resolving traumatic skin lesion on his back. Biopsy showed fungal elements, and on fungal culture, <i>Rhizopus arrhizus</i> (formerly <i>R. oryzae</i>) was isolated. Cutaneous mucormycosis is an important diagnostic consideration for a non-resolving skin lesion in an immunocompromised host. Early tissue sampling is key, and diagnostic certainty is particularly important because first line therapy, liposomal amphotericin B, has significant systemic toxicities, notable renal toxicity, and is therefore challenging to continue empirically. Surgical debridement is an integral part of therapy, highlighting the need for early multidisciplinary care in patients with cutaneous mucormycosis.</AbstractText><CopyrightInformation>&#xa9; 2023 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beliavsky</LastName><ForeName>Alina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Unity Health Toronto (St Joseph's Health Centre), 30 The Queensway, Toronto, ON, M6R 1B5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krajden</LastName><ForeName>Sigmund</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Unity Health Toronto (St Joseph's Health Centre), 30 The Queensway, Toronto, ON, M6R 1B5, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Cir, Toronto, ON, M5S 1A8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Zared</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Cir, Toronto, ON, M5S 1A8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Pathology Division, Unity Health Toronto (St Joseph's Health Centre), 30 The Queensway, Toronto, ON, M6R 1B5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Cir, Toronto, ON, M5S 1A8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, 155 College St., Room 500, Toronto, ON, M5T 3M7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sporometrics, 219 Dufferin St #20c, Toronto, ON, M6K 3J1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Summerbell</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, 155 College St., Room 500, Toronto, ON, M5T 3M7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sporometrics, 219 Dufferin St #20c, Toronto, ON, M6K 3J1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Med Mycol Case Rep</MedlineTA><NlmUniqueID>101598259</NlmUniqueID><ISSNLinking>2211-7539</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cutaneous</Keyword><Keyword MajorTopicYN="N">Immunocompromised</Keyword><Keyword MajorTopicYN="N">Mucormycosis</Keyword><Keyword MajorTopicYN="N">Rhizopus</Keyword><Keyword MajorTopicYN="N">Traumatic</Keyword></KeywordList><CoiStatement>None to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37808221</ArticleId><ArticleId IdType="pmc">PMC10551548</ArticleId><ArticleId IdType="doi">10.1016/j.mmcr.2023.100607</ArticleId><ArticleId IdType="pii">S2211-7539(23)00039-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ibrahim A.S., Spellberg B., Walsh T.J., Kontoyiannis D. Pathogenesis of mucormycosis. CID. 2012;54(Suppl 1):S16&#x2013;S22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286196</ArticleId><ArticleId IdType="pubmed">22247441</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoesly P.M., Pool S., Hoesly F.J. Post-traumatic cutaneous mucormycosis. IDCases. 2021;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8138723</ArticleId><ArticleId IdType="pubmed">34036043</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Lobato E., Ramirez-Hobak L., Aquino-Matus J.E., Ramirez-Hinojosa J.P., Lozano-Fernandez V.H., Xicohtencatl-Cortes J., et al. Primary cutaneous mucormycosis caused by Rhizopus oryzae: a case report and review of literature. Mycopathologia. 2016;182(3&#x2013;4):387&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">27807669</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark J.M., Liu H., Collins S., Watson C., Ferber L., Richards W.T., et al. Am Surg; 2021. The Statewide Epidemiology of Mucormycosis Among Trauma Patients in Florida. Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="pubmed">34645294</ArticleId></ArticleIdList></Reference><Reference><Citation>Castrej&#xf3;n-P&#xe9;rez A.D., Welsh E.S., Miranda I., Ocampo-Candiani J., Welsh O. Cutaneous mucormycosis. An. Bras. Dermatol. 2017;92(3):304&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5514567</ArticleId><ArticleId IdType="pubmed">29186239</ArticleId></ArticleIdList></Reference><Reference><Citation>Arn&#xe1;iz-Garc&#xed;a M.E., Alonso-Pe&#xf1;a D., Gonz&#xe1;lez-Vela Mdel C., Garcia-Palomo J.D., Sanz-Gimenez-Rico J.R., Arnaiz-Garcia A.M. Cutaneous mucormycosis: report of five cases and review of the literature. J. Plast. Reconstr. Aesthetic Surg. 2009;62(11):e434&#x2013;e441.</Citation><ArticleIdList><ArticleId IdType="pubmed">18684680</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyengar S., Chambers C.J., Millsop J.W., Fung M.A., Sharon V.R. Purple patches in an immunocompromised patient: a report of secondary disseminated cutaneous mucormycosis in a man with chronic lymphocytic leukemia. Dermatol. Online J. 2017;23(3)</Citation><ArticleIdList><ArticleId IdType="pubmed">28329517</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh T.J., Hospenthal D.R., Petraitis V., Kontoyiannis D. Necrotizing mucormycosis of wounds following combat injuries, natural disasters, burns, and other trauma. J Fungi (Basel) 2019;5(3):57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6787580</ArticleId><ArticleId IdType="pubmed">31277364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenane P., Keane C.O., Loughlin S.O. Mucormycosis infection presenting as a non-healing ulcer in an immunocompromised patient. Clin. Exp. Dermatol. 2003;28(2):157&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">12653703</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornely O.A., Alastruey-Izquierdo A., Arenz D., Chen S.C.A., Dannaoui E., Hochhegger B., et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical Mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect. Dis. 2019;19(12):e405&#x2013;e421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8559573</ArticleId><ArticleId IdType="pubmed">31699664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>